Revisão sistemática | Cannabis e canabinoides para tratamento sintomático de pessoas com esclerose múltipla.

Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis – Cochrane Library

Resumo: Cannabis and cannabinoids for people with multiple sclerosis – Cochrane Library

Comentário no Twitter

💚A UK survey found that 1 in 5 people with #MS reported they used #Cannabis to manage symptoms.
🤔 Does it work? Are there harms?
📚 Cochrane systematic review looks at 25 RCTs ➡️ https://t.co/HCt6Cx3suo#MedicalMarijuana #MultipleSclerosis pic.twitter.com/wjDTXXEciM

— The Cochrane Library (@CochraneLibrary) May 5, 2022